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Abstract Differentiation among regioisomers of synthetic
cannabinoids in forensic drug analysis is a crucial issue,
since all isomers are not regulated by law. New equivalent
analogs obtained via minor modification of their preexist-
ing molecules keep on emerging. Isomers formed via
substitutional exchange are also a cause for concern. This
study is focused on the isomeric molecules that stem from
minor modifications of 5F-PB-22. The analytical properties
of these molecules and methods of differentiation are
reported. Scan mode analysis using gas chromatography–
electron ionization-mass spectrometry (GC–EI-MS) was
performed using the authentic 5F-PB-22 standard, five
regioisomeric quinolinyl ester indoles, and five regioiso-
meric isoquinolinyl ester indoles. Because it was not pos-
sible to separate 5F-PB-22 from the 5-hydroxyquinoline
isomer using GC and all analytes showed similar EI mass
spectra, liquid chromatography (LC)–tandem mass spec-
trometry analysis was performed. Using LC, a successful
separation of 5F-PB-22 from all isomers could be achieved.
Based on the electrospray ionization-mass spectra, the
protonated molecular ion at m/z 377.2 was selected as the
precursor ion for the regioisomeric and structural isomeric
differentiation. Collision-induced dissociation provides
relative intensity differences in the product ions among the
isomers, enabling mass spectrometric differentiation of the
isomers. To our knowledge, this is the first report on mass
spectrometric differentiation of 5F-PB-22 and its ten
isomers.
Keywords Synthetic cannabinoids  Quinolinyl- and
isoquinolinyl-substituted regioisomers of 5F-PB-22  Gas
chromatography–electron ionization–mass spectrometry 
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Introduction
An increasing number of new psychoactive designer drugs
have emerged worldwide during the last decade [1]. Syn-
thetic cannabinoids (SCs) constitute a major share of drug
abuse in Japan as well as in European countries [2–5]. A
survey of designer drugs available in the Japanese market
was conducted under the leadership of the National Insti-
tute of Health Sciences (Tokyo). The identification of
known SCs and the structural determination of newly
emergent SCs were achieved using a combination of
technologies such as hyphenated chromatographic proce-
dures [gas chromatography–tandem mass spectrometry
(GC–MS-MS) and liquid chromatography (LC)–MS-MS]
and nuclear magnetic resonance spectroscopy [6–10].
Since new structurally modified analogs have been
continuously emerging in the market, avoiding/reducing
expansion of such illegal species is a never-ending chal-
lenge for governmental authorities, and the ‘‘cat-and-
mouse game’’ between regulators and drug manufacturers
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is ongoing. For effective control of these new psychoactive
substances, several legislative approaches have been
implemented at the national level. The Ministry of Health,
Labour and Welfare of Japan amended the Pharmaceutical
Affairs Law in 2006 to implement a new regulatory cate-
gory, called ‘‘Designated Substances (DSs)’’. The most
effective deterrent, a comprehensive regulatory system
(generic scheduling) for naphthoylindole-type SCs and
synthetic cathinones, was introduced to DSs in 2013. As of
April 2016, 2343 compounds are controlled as DSs. The
number of vendors on the street and the Internet has been
reduced after the repeated expansion of DSs. On the con-
trary, such government control of designer SCs may iron-
ically result in the continuing production of new designer
drugs and an expansion of structurally related analogs in
the clandestine market.
SCs bear the agonistic property for both cannabinoid
receptors (CB1 and CB2), with various affinities and selec-
tivities. The potential pharmacological activity on the CB1
receptors is responsible for the psychological effect and drug
abuse [11, 12]. In the indole class SCs, indole-3-carboxylic
acid ester derivatives with variation of the functional groups
on the indole core constitute one of the representative SC
groups in the DS list in Japan. The indole-3-carboxylates
substituted by the 8-quinolinyl moiety (e.g., PB-22, 5F-PB-
22, BB-22, FUB-PB-22) and the 1-naphthoyl moiety (e.g.,
FDU-PB-22) constitute themajority in this class (Fig. 1). 5F-
PB-22 (also known as 5F-QUPIC) has been controlled as DS
in 2013, and then has been re-categorized from DS to a
narcotic in 2014 in Japan. Despite strict control under the
Narcotics and Psychotropics Control Law, continuous sur-
vey of designer drugs in illegal markets by several prefec-
tural governments, including Gifu, resulted in the ongoing
detection of 5F-PB-22 in 2015 [13].
The next wave of SCs may include the structural vari-
ations resulting from positional isomerism. The funda-
mental studies on the positional isomer differentiation have
only been performed using 1-alkyl-3-acylindoles, including
JWH-081 and JWH-018, under the prospect of their future
abuse [14–21]. However, there are no reports about ester-
or amide-type SCs. We focused on 5F-PB-22, one of the
ester-type SCs, and investigated the positional isomer dif-
ferentiation of 5F-PB-22 involving five hydroxyquinoline
isomers and five hydroxyisoquinoline isomers using GC–
MS and LC–MS-MS.
Materials and methods
Reagents and chemicals
The structures of the 11 quinolinyl- and isoquinolinyl-
substituted 1-(5-fluoropentyl)-1H-indole-3-carboxylates
used in this study are shown in Figs. 1 and 2. Quinolin-8-yl
1-(5-fluoropentyl)-1H-indole-3-carboxylate (5F-PB-22: 1);
its five hydroxyquinoline isomers [5F-PB-22 7-hydrox-
yquinoline isomer (7Q isomer, 2), 5F-PB-22 6-hydrox-
yquinoline isomer (6Q isomer, 3), 5F-PB-22
5-hydroxyquinoline isomer (5Q isomer, 4), 5F-PB-22
4-hydroxyquinoline isomer (4Q isomer, 5), 5F-PB-22
3-hydroxyquinoline isomer (3Q isomer, 6)]; and its five
hydroxyisoquinoline isomers [5F-PB-22 8-hydroxyiso-
quinoline isomer (8IQ isomer, 7), 5F-PB-22 7-hydroxy-
isoquinoline isomer (7IQ isomer, 8), 5F-PB-22
6-hydroxyisoquinoline isomer (6IQ isomer, 9), 5F-PB-22
5-hydroxyisoquinoline isomer (5IQ isomer, 10), and 5F-
PB-22 4-hydroxyisoquinoline isomer (4IQ isomer, 11)]
were purchased from Cayman Chemical (Ann Arbor, MI
USA). The stock standard solutions of these compounds
were prepared at a concentration of 1 mg/mL (in acetoni-
trile) and were stored at -20 C until analysis. These
solutions were diluted in acetonitrile to appropriate con-
centrations prior to analysis. All other chemicals and sol-
vents were of analytical reagent grade or LC–MS grade.
Twelve herbal products (GP-2015-01 to GP-2015-12) were
purchased via the Internet in March 2015 in Japan. All the
products contained approximately 3–4 g of mixed dried
plants.
Preparation of sample solution
The herbal-type product (30 mg) was crushed to a powder
and extracted with 3 mL of methanol or acetonitrile under
ultrasonication for 10 min. After centrifugation (5 min,
3000 rpm), the supernatant solution was passed through a
membrane filter (Millex-LH 0.45 lm filter unit; Merck
Millipore, Darmstadt, Germany). Moreover, if necessary,
the solution was diluted with methanol or acetonitrile to a
suitable concentration before instrumental analysis.
Fig. 1 Chemical structures of synthetic cannabinoids having an
indole core with 3-carboxylic acid ester
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Analytical methods
GC–MS analysis was performed using a TRACE 1310 GC
and ISQ LT (Thermo Fisher Scientific, Waltham, MA,
USA). Samples were separated using a DB-5MS capillary
column (30 m 9 0.25 mm i.d.; 0.25 lm film thickness;
Agilent Technologies, Santa Clara, CA, USA) with helium
as the carrier gas, at a constant flow rate of 1.0 mL/min.
The oven temperature was programmed as follows: held at
50 C for 1 min, linearly ramped at 10 C/min to 310 C,
and held at 310 C for 12 min. The injector temperature
was set to 250 C, and the injection volume was 1 lL
(splitless mode). The GC interface and ion-source tem-
perature were maintained at 280 and 250 C, respectively.
Ionization was performed in the electron ionization (EI)
mode at 70 eV. A mass spectral library search was per-
formed using the Searchable Mass Spectral Library Ver-
sion 2.2 downloaded from the provider’s website [22].
GC–MS-MS was performed using an Agilent 7890A/7000
GC/MS Triple Quad (Agilent Technologies). The positive EI
mode was employed. Samples were introduced via a DB-
5MS ? DGcapillary column (30 m 9 0.25 mmi.d.; 0.25 lm
film thickness with 10 m DuraGuard; Agilent Technologies).
The analytical conditions were similar to those in the GC–MS
analysis. Product ion spectra were obtained using N2 as the
collisiongas (1.5 mL/min)byvarying the collision energy (CE)
from 5 to 35 V, in units of 10 V.
LC equipped with a photodiode array (PDA) detector
analysis was performed on an Agilent Technologies liquid
chromatograph (1100 series). Chromatographic separation
was carried out on an Atlantis T3 column (150 9 4.6 mm
i.d., particle size 5 lm; Waters, Milford, MA, USA). The
mobile phase comprised (A) 0.1 % formic acid in water
and (B) 0.1 % formic acid in acetonitrile. The column was
maintained at 40 C, and the gradient program was as
follows: linear gradient of B from 5 to 90 % from 0 to
45 min and isocratic elution of 90 % B from 45 to 60 min.
The flow rate and the injection volume were 1.0 mL/min
and 10 lL, respectively.
LC–MS analysis was performed on an Agilent 1100
Series LC/MSD-equipped with electrospray ionization
(ESI) and an Atlantis T3 column (150 9 2.1 mm i.d.,
particle size 5 lm; Waters). The mobile phase and column
temperature were similar to those in LC–PDA. The flow
rate and injection volume were 0.2 mL/min and 2 lL,
respectively.
Fig. 2 Chemical structures of ten isomers of 5F-PB-22 (1). 2, 5F-PB-
22 7-hydroxyquinoline isomer (7Q isomer); 3, 5F-PB-22 6-hydrox-
yquinoline isomer (6Q isomer); 4, 5F-PB-22 5-hydroxyquinoline
isomer (5Q isomer); 5, 5F-PB-22 4-hydroxyquinoline isomer (4Q
isomer); 6, 5F-PB-22 3-hydroxyquinoline isomer (3Q isomer); 7, 5F-
PB-22 8-hydroxyisoquinoline isomer (8IQ isomer); 8, 5F-PB-22
7-hydroxyisoquinoline isomer (7IQ isomer); 9, 5F-PB-22 6-hydrox-
yisoquinoline isomer (6IQ isomer); 10, 5F-PB-22 5-hydroxyisoquino-
line isomer (5IQ isomer); and 11, 5F-PB-22 4-hydroxyisoquinoline
isomer (4IQ isomer)
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LC–MS-MS analysis was performed on a 1200 Series
LC (Agilent Technologies) and a 4000 QTRAP (AB Sciex,
Framingham, MA, USA) equipped with ESI setup and an
Atlantis T3 column (150 9 2.1 mm i.d., particle size
5 lm; Waters). The mobile phase and column temperature
were the same as those in LC–PDA. The flow rate was
0.2 mL/min, and the injection volume was 1 lL. The MS
was operated in the positive mode. The ion spray voltage
was 5500 V, and the desolvation temperature was 600 C.
Product ion spectra were obtained at CEs of 10, 20, 30, and
35 V.
Results and discussion
Identification of 5F-PB-22 (1) from herbal products
During the course of the Gifu prefectural governmental
program to suppress drug abuse in 2015, 12 unknown
herbal-type products (GP-2015-01 to GP-2015-12) were
purchased on the Internet, and comprehensive analyses
were performed using GC–MS, LC–PDA, and LC–MS.
Identification of the detected peaks from each analytical
technique was first achieved using the available database
and finally by comparison of the data obtained from an
authentic standard. This resulted in the identification and
quantification of a narcotic 5F-PB-22 from two herbal
products, GP-2015-04 (65 mg/g) and GP-2015-05 (82 mg/
g), respectively named LAST Kou No. 1 and No. 2 [13].
LC–PDA and LC–MS analyses of the two herbal products
showed a peak that had retention time (Rt), UV spectrum,
and mass spectrum coincident with those of the reference
standard of 5F-PB-22. The results of GC–MS analysis
obtained from GP-2015-05 are shown in Fig. S1. The
examination directed toward detections of the quinolinyl-
and isoquinolinyl-substituted regioisomers of 5F-PB-22
were also conducted thoroughly by all the procedures
described in the following sections. However, the authors
failed to detect the isomer(s) from the authentic herbal
products.
It is well known that SCs having a heat-unstable core
skeleton of (1H-indole)-3-carboxylate tend to give analytical
artifacts, resulting from the transesterification reaction,
when they are analyzed by GC–MS in the presence of
methanol or ethanol [23, 24]. The degradation and esterifi-
cation occur in the injection port of the GC instrument. We
also demonstrated the detection of decomposed 5F-PB-22
during the analysis of GP-2015-04 and GP-2015-05. Intense
peaks corresponding to the methyl ester (methyl 1-(5-fluo-
ropentyl)-(1H-indole)-3-carboxylate) (Rt = 20.91 min),
8-hydroxyquinoline (Rt = 11.51 min) and a small peak
corresponding to the intact 5F-PB-22 (Rt = 31.58 min)
were observed in the total ion chromatogram in the presence
of methanol (Fig. S1a). To avoid a low sensitivity for the
targeted analysis of SCs with (1H-indole)-3-carboxylate,
acetonitrile was adopted as the solvent for extraction of all
herbal products and in the preparation of standard solutions
of authentic samples. This resulted in a higher sensitivity for
the target molecule, 5F-PB-22 (Fig. S1b).
GC–MS and GC–MS-MS analyses
EI mass spectra of the reference standards of 5F-PB-22 (1)
and its isomers (2–11) are shown in Fig. S2. These EI mass
spectra were acquired individually following sample
injection using GC–MS. 5F-PB-22 (1) and all ten isomers
(2–11) equally showed a small molecular ion peaks at
m/z 376. The ion at m/z 232 ([M–144]?: C14H15FNO
?)
occurred as the base peak for each of the 11 compounds
and represents the a-cleavage of a carbonyl group, i.e., the
loss of a hydroxyquinoline radical from the molecular ion
to afford an N-1-(5-fluoropentyl)-indolylacylium ion
(Fig. 3). Additionally, all the compounds showed charac-
teristic fragmentation patterns for 3-acylindoles, resulting
in fragments at m/z 144 and 116 of similar relative inten-
sities. 5F-PB-22 (1) and its ten isomers (2–11) were not
distinguishable based on their EI mass spectra. Structural
isomeric differentiation was also investigated using the
collision-induced dissociation (CID) of ions for the
molecular ion peak (m/z 376) and the base peak (m/z 144).
The product ion spectra of m/z 376 for 5F-PB-22 (1) and its
ten isomers (2–11) had a very low sensitivity due to an
insufficient precursor ion; most molecular ions were dis-
rupted by a-cleavage with EI. It was estimated that the
precursor ion at m/z 144 was attributed to C9H6NO
?, not
only due to the indolylacylium ion [18–21, 25, 26], but also
due to the positively charged quinolinol moiety present in
2–6 [10, 24] or the isoquinolinol moiety in 7–11. However,
all the compounds (1–11) yielded identical product ion
spectra of m/z 144 (Fig. S3), which suggested that the
abundance of the m/z 144 ion was due to the 3-acylindole
ring rather than the hydroxy(iso)quinoline ring. The dif-
ferentiation of 5F-PB-22 (1) and its ten isomers (2–11),
based on the product ion spectra acquired from GC–MS–
MS, was unfortunately unsuccessful.
The two characteristic fragment ions at m/z 144
(C9H6NO
?) and 116 (C8H6N
?) arose from the elimination
of olefin (5-fluoro-1-pentene) from the N-1-(5-fluo-
ropentyl)-indolylacylium ion and the subsequent loss of
CO [25]. The olefin elimination occurred with rearrange-
ment of an H-atom from the m/z 232 ion bearing a posi-
tively charged N-atom resonance, as illustrated in Fig. 3
[20]. The reaction requires the existence of an N-sub-
stituent with an H-atom at a b position relative to the indole
core. Previous reports showed supporting evidence for the
elimination mechanism in the EI mass spectra from two
Forensic Toxicol (2017) 35:56–65 59
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quinolin-8-yl 1H-indole-3-carboxylates, BB-22 [10] and
FUB-PB-22 [9] (Fig. 1). The former has a cyclohexyl-
methyl group with a b H-atom and yields the m/z 144 ion
due to elimination of the substituent. The latter, substituted
with a fluorobenzyl group without such an H-atom, did not
show any m/z 144 ion. This evidence further reinforces the
inference that the m/z 144 ion is formed due to the
indolylacylium ion alone and stems from the N-1-(5-fluo-
ropentyl)-indolylacylium ion at m/z 232. The EI mass
spectra of some synthetically prepared degradation prod-
ucts of PB-22, without a quinolinyl group, have been
reported to show the intense product ion at m/z 144 [24],
which further supports the conclusion that the m/z 144 ion
is formed from the indolylacylium ions.
GC studies
The GC Rts of 5F-PB-22 (1) and its ten isomers (2–11) are
shown in Fig. 4. Under the present experimental condi-
tions, the chromatography yielded excellent resolution
between 1 and each regioisomer (2–11), except for 5Q (4)
and 4Q (5) isomers. The first compound that eluted from
the column was 5Q isomer (4) (Rt = 31.60 min), followed
in order by 1 (Rt = 31.63 min), 5 (Rt = 31.69 min), and
5IQ isomer (10) (Rt = 31.91 min). The other compounds
(2, 3, 6–9, and 11) were detected in the region
Rt = 32.30–33.45 min. 5Q isomer (4) and 4Q isomer (5)
were very close to 1 in retention time. Analysis of a mix-
ture of 1 and 4 at the same concentration resulted in a
single and symmetric peak (Fig. S4a). A mixture of 1 and 5
showed a split in the peak (Fig. S4b). These results show
that the retention properties of 4 and 5 are extremely
similar to 1 and suggest that further combined analysis
using hyphenated methods must be performed for these
isomers.
GC shows that six quinolinyl 1-(5-fluoropentyl)-1H-in-
dole-3-carboxylates (1–6) can be grouped into two (Group
A: 4, 1, and 5; Group B: 6, 3, and 2) categories according to
their retention times and structural features (Fig. 4). It is
interesting that compounds from group A bear a common
structural feature in the quinolinyl moiety, where the O-
atom is substituted closest to the C-atoms, C4a or C8a, of
the quinoline ring. These three compounds have in com-
mon the close intramolecular relationship between the two
indole substituents, where a quinoline ring and indole ring
situated angularly form more compact structures compared
to the compounds from group B. The 5-fluoropentyl and
quinolinyl groups are more crowded in these three com-
pounds, suggesting that interactions between the two
groups minimize the retention time relative to the other
isomers in group B. Compounds of group B, on the other
hand, also bear a common structural feature in the quino-
linyl moiety, where the O-atom is substituted farthest from
C4a or C8a of the quinoline ring. The quinoline ring and
indole ring are positioned linearly to form an extended
structure that would contribute to the similar physical
properties observed in compounds from Group B. From the
conformational search, performed using Pcmodel with the
MMFF94 force field (Serena Software, Bloomington, IN,
USA), energy-minimized structures were obtained for
compounds 1–6. The results for 5F-PB-22 (1) and 7Q
isomer (2) are shown in Fig. 5, and indicate a closer
alignment of the quinoline ring and 5-fluoropentyl chain on
the indole ring for 1 and a more extended geometry for 2.
These observations support the above-mentioned argu-
ments on the structural features of the molecules. The same
Fig. 3 Putative fragmentation scheme for 5F-PB-22 and its isomers following electron ionization
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Fig. 4 Gas chromatographic retention times for 5F-PB-22 and its isomers
Fig. 5 Energy-minimized
structures for 1 5F-PB-22 and 2
7Q isomer based on
conformational search using
Pcmodel with the MMFF94
force field
Fig. 6 Liquid chromatographic retention times for 5F-PB-22 and its isomers
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arguments apply for retention properties and the structural
features of five isoquinolinyl 1-(5-fluoropentyl)-1H-indole-
3-carboxylates (7–11), which show a relatively shorter
retention time in the case of group A (10, 11, and 7) with
compact structural features, and an increased retention time
for group B (8 and 9) with extended structural features
(Fig. 4).
LC–PDA and LC–MS analyses
LC analyses, using LC–MS and LC–PDA, were employed
to develop suitable procedures for the separation of 5F-
PB-22 (1) and each of the ten isomers (2–11). The chro-
matogram from LC–MS showed that the peaks corre-
sponding to 5F-PB-22 (1) and ten isomers (2–11) were in
Fig. 7 Product ion spectra of
precursor ion at m/z 377 for 5F-
PB-22 and five Q isomers at
CEs of 10 V (left) and 20 V
(right) on LC–MS-MS. a 5F-
PB-22, b 7Q isomer, c 6Q
isomer, d 5Q isomer, e 4Q
isomer, and f 3Q isomer
62 Forensic Toxicol (2017) 35:56–65
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the region of Rt = 29.11–40.49 min (Fig. 6). LC analysis
facilitated the complete separation of 1 (Rt = 39.96 min),
4 (Rt = 36.36 min), and 5 (Rt = 34.43 min), although
they overlapped during GC analysis. The compounds
studied exhibited incomparable UV absorption spectra
with similarity over the range of 200–350 nm (Fig. S5).
All the isomeric compounds (2–11) exhibitedmass spectra
similar to 5F-PB-22 (1), which showed a quasi-molecular
ion at m/z 377 and a fragment ion at m/z 232, on LC–MS
analysis (data not shown).
LC–MS–MS analysis
Mass spectrometric differentiation among 5F-PB-22 (1)
and its ten isomers (2–11) was attempted using CID by
targeting the protonated molecular ion at m/z 377.2 as the
precursor ion. The analyses were performed at CEs of 10,
20, 30, and 35 V using an LC–MS-MS in the ESI mode.
The product ion spectra for 5F-PB-22 (1) and five Q iso-
mers (2–7) at CEs of 10 and 20 V are shown in Fig. 7. The
major product ion was only at m/z 232, and the other
fragment ion was hardly observed. The only difference
among the product ion spectra of the ten isomers was their
relative intensities of the product ion at m/z 232, which was
used for isomer differentiation. The relative intensities are
summarized in Table 1, based on the precursor ion at
m/z 377 and the product ion at m/z 232. At a CE of 10 V,
5F-PB-22 (1) and 4Q isomer (5) produced the product ion
at m/z 232 with relative intensities of 57 and 100 %,
respectively. For nine isomers (2–4 and 6–11), other than
4Q isomer (5), the product ions at m/z 232 were not
detected or were detected at very low relative intensities
(\10 %). At a CE of 20 V, 5F-PB-22 (1) showed ions at
m/z 232 and 377 with relative intensities of 100 and 11 %,
respectively. The precursor ion at m/z 377 was not detected
at CEs of 30 and 35 V. The relative intensities differed
from isomer to isomer depending on CE. This reflects the
difference in energy required for a-cleavage that depends
on the molecular structure of each isomer. Based on a
relative-intensity comparison among 5F-PB-22 (1) and its
five Q isomers (2–6), the energy required for a-cleavage is
estimated as follows: 6Q isomer[ 3Q isomer[ 5Q iso-
mer[ 7Q isomer[ 5F-PB-22[ 4Q isomer. As a result,
isomer differentiation was possible based on the product
ion spectra at several steps of CE using LC–MS-MS. It
would be effective to confirm the conformity of the relative
intensity with a reference standard using LC–MS-MS for
preventing the misidentification of these isomers.
Conclusions
We conducted hyphenated chromatographic analysis for
regioisomers of hydroxyquinolinyl ester indoles and
hydroxyisoquinolinyl ester indoles of 5F-PB-22. All isomers
were indistinguishable from 5F-PB-22 by EI–MS and EI–
MS–MS analyses coupled to a GC system, due to their
superimposable spectra. SCs having a carboxy ester group at
the C-3 position of indole hardly generate a detectable ion
stemming from quinolinyl- or isoquinolinyl-moiety, which
renders structural differentiation difficult. However, all iso-
mers were distinguishable from 5F-PB-22 by combining
results from GC and LC separations. Although the GC sys-
tem showed close retention among 5F-PB-22 (1), 5Q isomer
(4), and 4Q isomer (5), they were completely resolved in the
LC system usingODS adsorbent. The elution order in theGC
system showed that the stereochemically extended isomers
have a higher affinity for the capillary column.While the UV
and ESI mass spectra obtained from the LC systemwere also
not suitable for structural differentiation due to their close
Table 1 Relative intensities of
the product ions observed by
liquid chromatography–tandem
mass spectrometry
Compound CE 10 V CE 20 V CE 30 V CE 35 V
m/z 232 m/z 377 m/z 232 m/z 377 m/z 232 m/z 377 m/z 232 m/z 377
5F-PB-22 (1) 57.2 100 100 11.0 100 – 100 –
7Q isomer (2) 3.8 100 47.7 100 100 4.5 100 –
6Q isomer (3) – 100 4.9 100 87.9 100 100 24.4
5Q isomer (4) 2.8 100 28.7 100 100 10.6 100 –
4Q isomer (5) 100 45.9 100 – 100 – 100 –
3Q isomer (6) – 100 19.0 100 100 35.5 100 –
8IQ isomer (7) – 100 32.1 100 100 – 100 –
7IQ isomer (8) – 100 2.0 100 79.6 100 100 38.1
6IQ isomer (9) – 100 35.1 100 100 3.4 100 –
5IQ isomer (10) – 100 – 100 100 95.0 100 26.6
4IQ isomer (11) 4.1 100 63.2 100 100 2.6 100 –
– Not observed; CE collision energy, Q hydroxyquinoline, IQ hydroxyisoquinoline
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similarity, ESI-MS-MS analysis enabled the differentiation
of the isomers by means of differences in relative ion
intensity for the product ion at m/z 232, derived from the
protonated quasi-molecular ion at m/z 377. The recent
research trend regarding the structural differentiation of SCs,
supervised by Zaitsu [14, 16] and Clark [15, 17–20], is
focused on 1-alkyl-3-acylindoles. The series of isomers in
the GC system display significant fragment ions stemming
from the isomeric acyl cation at equivalent masses, with
some differences in relative abundance of these ions, which
is the biggest advantage of using EI-MS for this purpose. On
the other hand, 1-alkyl-(1H-indole)-3-carboxylates can
hardly generate a detectable ion from isomericmoieties, e.g.,
quinolinyl ester and isoquinolinyl ester conducted in the
current study, hindering the development of an analytical
procedure based on EI-MS for such compounds. This prob-
lem is encountered not only in case of EI-MS-aided struc-
tural differentiation of other regioisomeric quinolinyl or
isoquinolinyl ester indoles of PB-22, BB-22, and FUB-PB-
22, but also for indazole derivatives, e.g., 5F-NPB-22, NPB-
22, and FUB-NPB-22. In addition to the differentiation
procedure by resolution in GC and LC retention, an alternate
procedure is required for future forensic examinations. The
potential procedure aimed toward tackling this challenging
subject involves the utilization of product ion spectra in the
ESI mode, which would contribute to the analysis of forth-
coming designated substances.
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